Controversies in Lung Cancer: Heterogeneity in Treatment Recommendations for Stage III NSCLC According to Disease Burden and Oncogenic Driver Alterations
- Resource Type
- Article
- Source
- In
Clinical Lung Cancer June 2022 23(4):333-344 - Subject
- Language
- ISSN
- 1525-7304